Zobrazeno 1 - 10
of 179
pro vyhledávání: '"Mathias Mäurer"'
TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: Teriflunomide is a once-daily oral disease-modifying therapy (DMT) for the treatment of relapsing-remitting multiple sclerosis (RRMS). Only limited information is available about its real-world use and changes over time. Objectives: To co
Externí odkaz:
https://doaj.org/article/c5d0af7140314f509c64980ade915ac2
Autor:
Tjalf Ziemssen, Stephan Richter, Mathias Mäurer, Mathias Buttmann, Boris Kreusel, Anne-Maria Poehler, Maren Lampl, Ralf A. Linker
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Background:Ozanimod, a sphingosine 1-phosphate receptor 1 and 5 modulator, was approved as a disease-modifying therapy for active relapsing-remitting multiple sclerosis (RRMS) in 2020 and for active ulcerative colitis in 2021. Long-term, real-world s
Externí odkaz:
https://doaj.org/article/67d81f86e74244a989cc849bc871fdf0
Autor:
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of
Externí odkaz:
https://doaj.org/article/cee55fa870514dd8bb41f4326e4ce63e
Autor:
Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A. Kandenwein, Tjalf Ziemssen, Ralf A. Linker
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Background: With a large array of disease modifying therapies (DMTs) for relapsing-remitting MS (RRMS), identifying the optimal treatment option for the individual patient is challenging and switching of immunotherapies is often required. The objecti
Externí odkaz:
https://doaj.org/article/0fd09a02da39460790244fd7336013fa
Publikováno v:
Neurological Research and Practice, Vol 2, Iss 1, Pp 1-2 (2020)
Abstract We present the case of an 18 year old Caucasian with known celiac disease, who suffered a severe first attack of acute intermittent porphyria (AIP) with neuropsychiatric symptoms, severe tetraparesis and respiratory insufficiency. Treatment
Externí odkaz:
https://doaj.org/article/811fed7c2a5144acb02bbf30c06ad271
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 7, Pp 14951-14960 (2015)
Interferons are widely used platform therapies as disease-modifying treatment of patients with multiple sclerosis. Although interferons are usually safe and well tolerated, they frequently cause dermatological side effects. Here, we present a multipl
Externí odkaz:
https://doaj.org/article/935dbb00210e439692df557b35dfcb5d
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 7, Pp 14901-14911 (2015)
Multiple sclerosis (MS) patients, in general, show reduced physical function, physical activity, and quality of life. Positive associations between physical activity and quality of life have been reported. In particular, we were interested in the rel
Externí odkaz:
https://doaj.org/article/6623a6bced2e4337842bc2cc9e50e964
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 9 (2016)
The World Wide Web is increasingly used in therapeutic settings. In this regard, internet-based interventions have proven effective in ameliorating several health behaviors, amongst them physical activity behavior. Internet-delivered interventions ha
Externí odkaz:
https://doaj.org/article/dede202d187d4b948d58cd92e0624972
Autor:
Anne Waschbisch, Nicholas Sanderson, Markus Krumbholz, George Vlad, Diethilde Theil, Stefan Schwab, Mathias Mäurer, Tobias Derfuss
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115488 (2014)
Immunoglobulin-like transcript (ILT) 3 and 4 are inhibitory receptors that modulate immune responses. Their expression has been reported to be affected by interferon, offering a possible mechanism by which this cytokine exerts its therapeutic effect
Externí odkaz:
https://doaj.org/article/1793a7cc2238471ba49018c86c6f2172
Autor:
Alexander Tallner, René Streber, Christian Hentschke, Marc Morgott, Wolfgang Geidl, Mathias Mäurer, Klaus Pfeifer
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 10, p 1667 (2016)
Physical exercise is effective in improving functional outcomes in persons with multiple sclerosis (pwMS). We evaluated the feasibility and effectiveness of internet-based exercise training (e-training) for pwMS on health-related quality of life (HrQ
Externí odkaz:
https://doaj.org/article/abbe83c8acde403aa4e338a5528bc9e6